Answers are grounded in this paper and cite their sources.
The findings suggest that lowering serum cholesterol levels in patients with T2D and DPN is associated with a higher amount of nerve lesions and declining nerve conduction velocities and amplitudes. These findings may be relevant to emerging therapies that promote an aggressive lowering of serum cholesterol levels in patients with T2D.
No takes yet. Share an insight, caveat, or question.
Jende et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: